Triglyceride-glucose-Body Mass Index is linked to papillary thyroid carcinoma odds in China: a retrospective study - Top-Institutions - MDSpire

Triglyceride-glucose-Body Mass Index is linked to papillary thyroid carcinoma odds in China: a retrospective study

  • By

  • Guoqing Li

  • Qingyu Ren

  • Jiaqin Zhou

  • Hui Zhou

  • Yibo Wu

  • Ling Chen

  • Kai Jiang

  • March 30, 2026

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Endocrinology
    • Oncology
    • Cancer Epidemiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Oncology
    • Metabolic Disorders

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Oncology
    • Cancer Biology

  • #4

    Peking University Cancer Hospital & Institute
    Peking University Cancer Hospital & Institute

    Beijing, China

    Key Differentiators

    • Endocrinology
    • Oncology
    • Epidemiology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Oncology
    • Metabolic Research

Original Source(s)

Triglyceride-glucose-Body Mass Index is linked to papillary thyroid carcinoma odds in China: a retrospective study

  • by Guoqing Li, Qingyu Ren, Jiaqin Zhou, Hui Zhou, Yibo Wu, Ling Chen, Kai Jiang

  • March 30, 2026

Related Content

Polygenic Risk Score Translation Across Diverse Populations

Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety

National Institutes of Health–Supported Research on Ultraprocessed Foods